Differences between asthma exacerbations and poor asthma control

BACKGROUND Increased variation in peak expiratory flow (PEF) is characteristic of poorly controlled asthma, and measurement of diurnal variability of PEF has been recommended for assessment of asthma severity, including during exacerbations. We aimed to test whether asthma exacerbations had the same PEF characteristics as poor asthma control. METHODS Electronic PEF records from 43 patients with initially poorly controlled asthma were examined for all exacerbations that occurred after PEF reached a plateau with inhaled corticosteroid treatment. Diurnal variability of PEF was compared during exacerbations, run-in (poor asthma control), and the period of stable asthma before each exacerbation. FINDINGS Diurnal variability was 21.3% during poor asthma control and improved to 5.3% (stable asthma) with inhaled corticosteroid treatment. 40 exacerbations occurred in 26 patients over 2-16 months; 38 (95%) of exacerbations were associated with symptoms of clinical respiratory infection. During exacerbations, consecutive PEF values fell linearly over several days then improved linearly. However, diurnal variability during exacerbations (7.7%) was not significantly higher than during stable asthma (5.4%, p=0.1). PEF data were consistent with impaired response to inhaled beta2-agonist during exacerbations but not during poorly controlled asthma. INTERPRETATION Asthmatics remain vulnerable to exacerbations during clinical respiratory infections, even after asthma is brought under control. Calculation of diurnal variability may fail to detect important changes in lung function. PEF variation is strikingly different during exacerbations compared with poor asthma control, suggesting differences in beta2-adrenoceptor function between these conditions.

[1]  R. Lin,et al.  Association between reported use of inhaled triamcinolone and differential short-term responses to aerosolized albuterol in asthmatics in an emergency department setting. , 1994, Chest.

[2]  A. Rebuck,et al.  Assessment and management of severe asthma. , 1971, The American journal of medicine.

[3]  W. Busse,et al.  Virus-induced airway hyperresponsiveness and asthma. , 1998, American journal of respiratory and critical care medicine.

[4]  S. Johnston,et al.  Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. , 1995, American journal of respiratory and critical care medicine.

[5]  W. Busse,et al.  Parainfluenza 3 infection blocks the ability of a beta adrenergic receptor agonist to inhibit antigen-induced contraction of guinea pig isolated airway smooth muscle. , 1981, The Journal of clinical investigation.

[6]  D. Postma,et al.  The Effect of Reduction of Maintenance Treatment on Circadian Variation in Peak Expiratory Flow Rate Values in Asthmatic Children , 1988, Acta paediatrica Scandinavica.

[7]  P. Barnes,et al.  A Comparison of β-Adrenergic Receptors and In Vitro Relaxant Responses to Isoproterenol in Asthmatic Airway Smooth Muscle , 1992 .

[8]  S. Holgate,et al.  Mechanisms of virus induced exacerbations of asthma. , 1997, Thorax.

[9]  S. Johnston,et al.  Viruses as precipitants of asthma symptoms. I. Epidemiology , 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[10]  John Wlodarczyk,et al.  Using Quality-Control Analysis of Peak Expiratory Flow Recordings To Guide Therapy for Asthma , 1995, Annals of Internal Medicine.

[11]  M. Chan-yeung,et al.  Changes in peak flow, symptom score, and the use of medications during acute exacerbations of asthma. , 1996, American journal of respiratory and critical care medicine.

[12]  British,et al.  Asthma: analysis of sudden deaths and ventilatory arrests in hospital. , 1977, British medical journal.

[13]  D. Postma,et al.  Influence of treatment on peak expiratory flow and its relation to airway hyperresponsiveness and symptoms. The Dutch CNSLD Study Group. , 1994, Thorax.

[14]  A. Woolcock,et al.  Mite allergen (Der p 1) concentration in houses and its relation to the presence and severity of asthma in a population of Sydney schoolchildren. , 1995, The Journal of allergy and clinical immunology.

[15]  C. Jenkins,et al.  Standardization of ambulatory peak flow monitoring: the importance of recent beta2-agonist inhalation. , 1998, The European respiratory journal.

[16]  Stephen T Holgate,et al.  Community study of role of viral infections in exacerbations of asthma in 9-11 year old children , 1995, BMJ.

[17]  D. Postma,et al.  Exogenous stimuli and circadian peak expiratory flow variation in allergic asthmatic children. , 1996, American journal of respiratory and critical care medicine.

[18]  E. D. de KLERK,et al.  Experimental rhinovirus 16 infection. Effects on cell differentials and soluble markers in sputum in asthmatic subjects. , 1997, American journal of respiratory and critical care medicine.

[19]  J. Hogg.  The pathology of asthma. , 1993, Clinics in chest medicine.

[20]  K. Nicholson,et al.  Respiratory viruses and exacerbations of asthma in adults. , 1993, BMJ.

[21]  Alfred O. Berg,et al.  Clinical Guidelines And Primary Care Guidelines For The Diagnosis And Management Of Asthma , 2012 .

[22]  W. Busse.  Decreased granulocyte response to isoproterenol in asthma during upper respiratory infections. , 2015, The American review of respiratory disease.

[23]  J. Abisheganaden,et al.  A profile of acute asthma patients presenting to the emergency room. , 1996, Singapore medical journal.

[24]  W. Busse,et al.  The effects of rhinovirus infections on allergic airway responses. , 1995, American journal of respiratory and critical care medicine.

[25]  Wan Ariffin Bin Abdullah.  Singapore Med J , 1993 .

[26]  S. Johnston,et al.  Viruses as precipitants of asthma symptoms II. Physiology and mechanisms , 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[27]  B Higgins,et al.  Peak expiratory flow variability in the general population. , 1997, The European respiratory journal. Supplement.

[28]  J. Paterson,et al.  In vitro responsiveness of human asthmatic bronchus to carbachol, histamine, beta-adrenoceptor agonists and theophylline. , 1986, British journal of clinical pharmacology.

[29]  P. Barnes,et al.  Beta-adrenergic receptors and their regulation. , 1995, American journal of respiratory and critical care medicine.

[30]  E. D. Coleman,et al.  Viral respiratory tract infection and exacerbations of asthma in adult patients. , 1988, Thorax.

[31]  G. Guyatt,et al.  A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroid , 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[32]  C. Jenkins,et al.  Pitfalls in processing home electronic spirometric data in asthma. , 1998, The European respiratory journal.